7^th Cancer Diagnostics & Treatment Conference

About Conference

Conference Series llc LTD extends its heartfelt welcome to 7th Cancer diagnostics & Treatment Conference ’that will be held in Miami, USA during November 23-November 24, 2026. The conference will be organised around the theme  ‘Advancement of new techniques and toils in cancer diagnostics’

Cancer Diagnostics 2026 is the premier event that brings together a unique and International mix of experts, researchers and decision makers both from academia and industry across the globe to exchange their knowledge, experience and research innovations to build Cancer Research scientists, industrialists and entrepreneurs meet.             

Cancer Diagnostics 2026 conference will be organized by Conference Series which is comprised of 3000+ Global Events with over 1000+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse fields of Medical, Pharmaceutical, Clinical, Engineering, Science, Technology and Business World Cancer 2026 deals with study of basic researches in the field of cancer & oncology. It involves identifying causes and to develop strategies for diagnosis, prevention, treatment and cure for this dreadful disease.

We look forward to an exciting 3-day scientific event, business meeting, trade fair and exhibition in the alluring city of Dublin, Ireland.

Why to attend Cancer Diagnostics 2026?

Cancer Diagnostics 2026 is the main event that brings together a unique and international experts, scientists and decision makers both from academia and industry across the world to exchange their knowledge, expertise and research innovations in the arena of cancer treatment. This pinnacle brings together the senior level experts with a perfect blend for multidisciplinary collaboration between innovators, scientists, academicians from all over the world working in the different field of Cancer & Oncology Research

Sessions & Tracks

Cancer Diagnostics 2026 is a worldwide conference on the topics of the future direction of the Cancer Treatment. As the theme of the conference highlights ‘Advancement of new techniques and toils in cancer diagnostics’, the Conference is an outstanding international forum to present and discuss progress in exploration, expansion, ideals, and applications of the topics related to the Cancer & Oncology.

In addition to the multidisciplinary talks, Keynote sessions, and lectures relevant to cancer & oncology research, the Cancer Diagnostics 2026 is a complete 2-day event with panel discussions,

Scientific Session of the Conference includes:

Track 1: Cancer Diagnostics Tools, Technologies and Procedures

Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. We use sophisticated diagnostic technology to pinpoint and evaluate tumors, and develop a personalized treatment plan.

Cancer Diagnostics Conference | Cancer Conferences | Oncology Conferences Cancer Conferences 2026 | Cancer Science Conferences | Cancer Treatment Conferences | Cancer Surgery Conference | Cancer Cell Conference | Cancer Prevention Conferences | Cancer Radiation Therapy Conference.

European Cancer Society: EACR (European Association for Cancer Research), ESMO (European Society for Medical Oncology), ECCO (European Cancer Organisation), German Society of Radiation Oncology,

USA Cancer Societies: American Cancer Society, American Bladder Cancer Society, American Association for Cancer Research, American Society for Radiation Oncology,

Asian Cancer Societies: Asian Clinical Oncology Society, Asian Cancer Foundation, Association of Radiation Oncologists of India, Japanese Breast Cancer Society.

Track 2: Cancer Radiology

Radiation Oncology encompasses all aspects of research that impacts on the treatment of cancer using radiation. Radiation can be given as a curative modality, either alone or in combination with surgery and/or chemotherapy. It may also be used palliatively, to relieve symptoms in patients with incurable cancers. The Radiotherapy/radiation therapy is broadly segmented into Teleradiotherapy, Brachy-radiotherapy and Metabolic Radiotherapy. Nuclear medicine is a branch of medicine that uses radiation to provide information about the functioning of a person's specific organs or to treat disease. Medical imaging is the technique and process of creating visual representations of the interior of a body for clinical analysis and medical intervention, as well as visual representation of the function of some organs or tissues.

Cancer Diagnostics Conference | Cancer Conferences | Oncology Conferences | Cancer Conferences 2026 | Cancer Science Conferences | Cancer Treatment Conferences | Cancer Surgery Conference | Cancer Cell Conference | Cancer Prevention Conferences | Cancer Radiation Therapy Conference.

European Cancer Society: German Society of Radiation Oncology, EACR (European Association for Cancer Research), ESMO (European Society for Medical Oncology), ECCO (European Cancer Organisation)

USA Cancer Societies: American Society for Radiation Oncology, American Cancer Society, American Bladder Cancer Society, American Association for Cancer Research,   

Asian Cancer Societies: Japanese Breast Cancer Society, Asian Clinical Oncology Society, Asian Cancer Foundation, Association of Radiation Oncologists of India

Track 3: Cancer Biomarker

A cancer biomarker is an element or procedure that indicates the presence of cancer in the body. A biomarker may be any molecule released by presence a tumor or a specific indication of the body to the presence of cancer. Cancer biomarkers are usually biological molecules found in blood, other body fluids, or tissues that are a sign of a normal or abnormal process, or of a condition or disease.

Cancer Diagnostics Conference | Cancer Conferences | Oncology Conferences | Cancer Conferences 2026 | Cancer Science Conferences | Cancer Treatment Conferences | Cancer Surgery Conference | Cancer Cell Conference | Cancer Prevention Conferences | Cancer Radiation Therapy Conference.

European Cancer Society: German Society of Radiation Oncology, EACR (European Association for Cancer Research), ESMO (European Society for Medical Oncology), ECCO (European Cancer Organisation)

USA Cancer Societies: American Society for Radiation Oncology, American Cancer Society, American Bladder Cancer Society, American Association for Cancer Research,   

Asian Cancer Societies: Japanese Breast Cancer Society, Asian Clinical Oncology Society, Asian Cancer Foundation, Association of Radiation Oncologists of India

Track 4: Cancer & Biopsies

A biopsy is the removal of a small amount of tissue for examination under a microscope. Other tests can suggest that cancer is present, but only a biopsy can make a definite diagnosis. Sometimes, a biopsy may be performed with the help of an imaging test, such as an ultrasound, CT scan, or MRI (see below). Occasionally, surgery may be needed to get a tissue sample. The type of biopsy you receive depends on where the possible tumor is located

Cancer Diagnostics Conference | Cancer Conferences | Oncology Conferences | Cancer Conferences 2026 | Cancer Science Conferences | Cancer Treatment Conferences | Cancer Surgery Conference | Cancer Cell Conference | Cancer Prevention Conferences | Cancer Radiation Therapy Conference.

European Cancer Society: ECCO (European Cancer Organisation) ,German Society of Radiation Oncology, EACR (European Association for Cancer Research), ESMO (European Society for Medical Oncology),

USA Cancer Societies: American Association for Cancer Research, American Society for Radiation Oncology, American Cancer Society, American Bladder Cancer Society,   

Asian Cancer Societies: Association of Radiation Oncologists of India, Japanese Breast Cancer Society, Asian Clinical Oncology Society, Asian Cancer Foundation,

Track 5: Cancer Nanotechnology

Research on nanotechnology cancer therapy extends beyond drug delivery into the creation of new therapeutics available only through use of nanomaterial properties. Although small compared to cells, nanoparticles are large enough to encapsulate many small molecule compounds, which can be of multiple types. At the same time, the relatively large surface area of nanoparticle can be functionalized with ligands, including small molecules, DNA or RNA strands, peptides, aptamers or antibodies. These ligands can be used for therapeutic effect or to direct nanoparticle fate in vivo. These properties enable combination drug delivery, multi-modality treatment and combined therapeutic and diagnostic, known as “theranostic,” action. The physical properties of nanoparticles, such as energy absorption and re-radiation, can also be used to disrupt diseased tissue, as in laser ablation and hyperthermia applications.

Cancer Diagnostics Conference | Cancer Conferences | Oncology Conferences | Cancer Conferences 2026 | Cancer Science Conferences | Cancer Treatment Conferences | Cancer Surgery Conference | Cancer Cell Conference | Cancer Prevention Conferences | Cancer Radiation Therapy Conference.

European Cancer Society: ESMO (European Society for Medical Oncology), ECCO (European Cancer Organisation), German Society of Radiation Oncology, EACR (European Association for Cancer Research),

USA Cancer Societies: American Association for Cancer Research, American Society for Radiation Oncology, American Cancer Society, American Bladder Cancer Society,   

Asian Cancer Societies: Asian Cancer Foundation, Association of Radiation Oncologists of India, Japanese Breast Cancer Society, Asian Clinical Oncology Society,

Track 6: Clinical Cancer research

Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer, medical and hematological oncology, radiation therapy, pediatric oncology, pathology, surgical oncology, and clinical genetics. The applications of the disciplines of pharmacology, immunology, cell biology, and molecular genetics to intervention in human cancer are also included. One of the main interests of Clinical Cancer Research is on clinical trials that evaluate new treatments together with research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment.

Cancer Diagnostics Conference | Cancer Conferences | Oncology Conferences |Cancer Conferences 2026 | Cancer Science Conferences | Cancer Treatment Conferences | Cancer Surgery Conference | Cancer Cell Conference | Cancer Prevention Conferences | Cancer Radiation Therapy Conference.

European Cancer Society: EACR (European Association for Cancer Research), ESMO (European Society for Medical Oncology), ECCO (European Cancer Organisation), German Society of Radiation Oncology,

USA Cancer Societies: American Association for Cancer Research, American Society for Radiation Oncology, American Cancer Society, American Bladder Cancer Society,   

Asian Cancer Societies: Asian Clinical Oncology Society, Asian Cancer Foundation, Association of Radiation Oncologists of India, Japanese Breast Cancer Society,

Track 7: Cancer Vaccines and Therapeutics

 Cancer Vaccines generally either treats existing cancer or prevents development of a cancer. Cancer treatment vaccines are made up of cancer cells, parts of cells, or pure antigens. Sometimes a patient’s own immune cells are removed and exposed to these substances in the lab to create the vaccines. Therapeutic vaccines represent a viable option for active immunotherapy of cancers that aim to treat late stage disease by using a patient's own immune system. The promising results from clinical trials recently led to the approval of the first therapeutic cancer vaccine by the U.S. Food and Drug Administration.

Cancer Diagnostics Conference | Cancer Conferences | Oncology Conferences |Cancer Conferences 2026 | Cancer Science Conferences | Cancer Treatment Conferences | Cancer Surgery Conference | Cancer Cell Conference | Cancer Prevention Conferences | Cancer Radiation Therapy Conference.

European Cancer Society: EACR (European Association for Cancer Research), ESMO (European Society for Medical Oncology), ECCO (European Cancer Organisation), German Society of Radiation Oncology,

USA Cancer Societies: American Association for Cancer Research, American Society for Radiation Oncology, American Cancer Society, American Bladder Cancer Society,   

Asian Cancer Societies: Asian Clinical Oncology Society, Asian Cancer Foundation, Association of Radiation Oncologists of India, Japanese Breast Cancer Society,

Track 8: Predictive Cancer Biomarkers

Predictive cancer biomarkers hold the promise of early cancer detection, personalized treatment, and accurate patient monitoring. Cambridge Healthtech Institute’s Ninth Annual Predictive Cancer Biomarkers symposium will focus on current research regarding tumor pathways and biomarker discovery, the progress toward clinical applications such as early detection and therapy monitoring, and case studies focusing on clinical utility and actionability.

Cancer Diagnostics Conference | Cancer Conferences | Oncology Conferences |Cancer Conferences 2026 | Cancer Science Conferences | Cancer Treatment Conferences | Cancer Surgery Conference | Cancer Cell Conference | Cancer Prevention Conferences | Cancer Radiation Therapy Conference.

European Cancer Society: German Society of Radiation Oncology, EACR (European Association for Cancer Research), ESMO (European Society for Medical Oncology), ECCO (European Cancer Organisation)

USA Cancer Societies: American Cancer Society, American Association for Cancer Research, American Society for Radiation Oncology, American Bladder Cancer Society,   

Asian Cancer Societies: Association of Radiation Oncologists of India, Asian Clinical Oncology Society, Asian Cancer Foundation, Japanese Breast Cancer Society,

Track 9: Cancer Immunotherapy and Types

Immunotherapy  is treatment that uses your body's own immune system to help  fight cancer. Get information about the different types of immunotherapy and the    types of cancer they are used to treat.

• Monoclonal antibodies: which are drugs that are designed to bind to specific targets in the body. They can cause an immune response that destroys cancer cells
• Adoptive cell transfer: which is a treatment that attempts to boost the natural ability of your T cells to fight cancer? T cells are a type of white blood cell and part of the immune system. Researchers take T cells from the tumor. They then isolate the T cells that are most active against your cancer or modify the genes in them to make them better able to find and destroy your cancer cells.
• Cytokines: which are proteins that are made by your body’s cells. They play important roles in the body’s normal immune responses and also in the immune system’s ability to respond to cancer. The two main types of cytokines used to treat cancer are called interferons and interleukins.
• Treatment Vaccines: which work against cancer by boosting your immune system’s response to cancer cells. Treatment vaccines are different from the ones that help prevent disease.

Cancer Diagnostics Conference | Cancer Conferences | Oncology Conferences |Cancer Conferences 2026 | Cancer Science Conferences | Cancer Treatment Conferences | Cancer Surgery Conference | Cancer Cell Conference | Cancer Prevention Conferences | Cancer Radiation Therapy Conference.

European Cancer Society: ESMO (European Society for Medical Oncology), German Society of Radiation Oncology, EACR (European Association for Cancer Research), ECCO (European Cancer Organisation)

USA Cancer Societies: American Bladder Cancer Society, American Cancer Society, American Association for Cancer Research, American Society for Radiation Oncology,

Asian Cancer Societies: Japanese Breast Cancer Society, Association of Radiation Oncologists of India, Asian Clinical Oncology Society, Asian Cancer Foundation,

Track 10: Cancer Treatment and Therapies

Cancer is treated in several ways, depending on each person's medical condition and type of cancer. Common treatments involve chemotherapy and radiation therapy. Other treatments include surgery and biological therapies.

Cancer Diagnostics Conference | Cancer Conferences | Oncology Conferences |Cancer Conferences 2026 | Cancer Science Conferences | Cancer Treatment Conferences | Cancer Surgery Conference | Cancer Cell Conference | Cancer Prevention Conferences | Cancer Radiation Therapy Conference.

European Cancer Society: ESMO (European Society for Medical Oncology), German Society of Radiation Oncology, EACR (European Association for Cancer Research), ECCO (European Cancer Organisation)

USA Cancer Societies: American Bladder Cancer Society, American Cancer Society, American Association for Cancer Research, American Society for Radiation Oncology,

Asian Cancer Societies: Japanese Breast Cancer Society, Association of Radiation Oncologists of India, Asian Clinical Oncology Society, Asian Cancer Foundation,

 Track 11: Cancer Genomics and Epigenetics

The fundamental goal of Genomics and Epigenetics Division is to understand genome biology and its impact on disease. Genomics is the study of information that is encoded within the full DNA sequence complement of an organism. Epigenetics is the study of how DNA is organised and regulated in the cell to promote a stably heritable phenotype without alterations in the DNA sequence.

Cancer Diagnostics Conference | Cancer Conferences | Oncology Conferences |Cancer Conferences 2026 | Cancer Science Conferences | Cancer Treatment Conferences | Cancer Surgery Conference | Cancer Cell Conference | Cancer Prevention Conferences | Cancer Radiation Therapy Conference.

European Cancer Society: ESMO (European Society for Medical Oncology), German Society of Radiation Oncology, EACR (European Association for Cancer Research), ECCO (European Cancer Organisation)

USA Cancer Societies: American Bladder Cancer Society, American Cancer Society, American Association for Cancer Research, American Society for Radiation Oncology,

Asian Cancer Societies: Japanese Breast Cancer Society, Association of Radiation Oncologists of India, Asian Clinical Oncology Society, Asian Cancer Foundation,

Track 12: Cancer Diagnostics Market

Growing prevalence of oncologic cases, constant technological advancements in diagnostics, and increasing demand for effective screening tests are some of the prime factors spurring the demand for screening tools across the world. In addition, rising awareness and supportive government initiatives are some additional factors that are anticipated to boost the growth of the sector during the forecast period.

Cancer Diagnostics Conference | Cancer Conferences | Oncology Conferences |Cancer Conferences 2026 | Cancer Science Conferences | Cancer Treatment Conferences | Cancer Surgery Conference | Cancer Cell Conference | Cancer Prevention Conferences | Cancer Radiation Therapy Conference.

European Cancer Society: ESMO (European Society for Medical Oncology), German Society of Radiation Oncology, EACR (European Association for Cancer Research), ECCO (European Cancer Organisation)

USA Cancer Societies: American Bladder Cancer Society, American Cancer Society, American Association for Cancer Research, American Society for Radiation Oncology,

Asian Cancer Societies: Japanese Breast Cancer Society, Association of Radiation Oncologists of India, Asian Clinical Oncology Society, Asian Cancer Foundation,

Track 13: Recent Diagnostics Technologies

A thorough and accurate cancer diagnosis is the first step in developing an individualized cancer treatment plan. When you first visit one of our hospitals, we will perform a complete array of diagnostic tests to accurately confirm your diagnosis and plan your individualized treatment.

Cancer Diagnostics Conference | Cancer Conferences | Oncology Conferences |Cancer Conferences 2026 | Cancer Science Conferences | Cancer Treatment Conferences | Cancer Surgery Conference | Cancer Cell Conference | Cancer Prevention Conferences | Cancer Radiation Therapy Conference.

European Cancer Society: ESMO (European Society for Medical Oncology), German Society of Radiation Oncology, EACR (European Association for Cancer Research), ECCO (European Cancer Organisation)

USA Cancer Societies: American Bladder Cancer Society, American Cancer Society, American Association for Cancer Research, American Society for Radiation Oncology,

Asian Cancer Societies: Japanese Breast Cancer Society, Association of Radiation Oncologists of India, Asian Clinical Oncology Society, Asian Cancer Foundation

Track 14: Cancer Clinical Trails

As successful as researchers have been in using nanotechnology to address and solve many important questions in the laboratory, the ultimate measure of the field’s success lies in the translation of research discoveries to the clinic. Currently, multiple nanotechnology-enabled diagnostic and therapeutic agents are in clinical trials, and many more are nearing that goal.

Cancer Diagnostics Conference | Cancer Conferences | Oncology Conferences |Cancer Conferences 2026 | Cancer Science Conferences | Cancer Treatment Conferences | Cancer Surgery Conference | Cancer Cell Conference | Cancer Prevention Conferences | Cancer Radiation Therapy Conference.

European Cancer Society: EACR (European Association for Cancer Research), ESMO (European Society for Medical Oncology), German Society of Radiation Oncology, ECCO (European Cancer Organisation)

USA Cancer Societies: American Association for Cancer Research, American Bladder Cancer Society, American Cancer Society, American Society for Radiation Oncology,

Asian Cancer Societies: Asian Cancer Foundation, Japanese Breast Cancer Society, Association of Radiation Oncologists of India, Asian Clinical Oncology Society,

Market Analysis

1. Global Cancer Diagnostics & Treatment Market Landscape (2024–2034)

Cancer Diagnostics Market (Global)

• 2025 Estimated Value: ~USD 17.24 billion (global core diagnostics market).
• 2026 Projection: ~USD 18.51 billion.
• 2034 Forecast: ~USD 38.27 billion, growing at ~9.5 % CAGR (2026–2034).

Regional mix (2025):

• North America: ~36.8 % share.
• Asia-Pacific: fast-emerging growth with China and India leading contributions.
• Europe: steady growth with precision diagnostics integration.

Cancer Treatment & Therapeutics Market (Global)

• Oncology Drugs Market 2025: ~USD 242.5 billion.
• 2026 Projection: ~USD 267.2 billion.
• 2034 Forecast: ~USD 667.3 billion (strong demand for immunotherapies and targeted therapies).
• Broader Cancer Treatment (drugs + services): ~USD 282.3 billion in 2025 → ~USD 643.5 billion by 2034.

2. Country & Year-Wise Market Mix: Diagnostics + Treatment

Below are key markets with approximate values and mixed (diagnostics + treatment) perspectives for major years.

United States

Diagnostics:

• Leading global diagnostics share with high adoption of advanced tests.

Treatment:

• Largest oncology drug market globally in 2025.

Evolution:

*Data from regional oncology drug forecasts and share projections.

China

Diagnostics:

• Rapid growth in cancer diagnostics due to rising incidence and screening adoption.

Treatment:

• Largest oncology treatment market in Asia-Pacific with rapid therapy uptake.

Growth Pattern:

*China’s diagnostics are increasing volume share; biotech participation in global drug development is rising.

India

Diagnostics:

• High projected CAGR in diagnostics market.

Treatment:

• Growing treatment services due to infrastructure build-out.

Yearly Mix:

*India’s diagnostics and treatment markets are early-stage but high growth.

Japan

• Diagnostics growing due to aging population.
• Strong treatment adoption for advanced therapies.

Germany & UK (Europe)

• Europe holds steady large shares in both diagnostics and therapeutics.
• Germany and UK have significant market sizes in oncology drugs and precision diagnostics.

3. Regional Mix Trends (2024–2034)

North America

• Continues to dominate diagnostics and treatment markets with ~40+ % share in treatment drugs (2025).
• Diagnostics leadership driven by early detection programs and technology adoption.

Asia-Pacific

• Fastest regional growth for diagnostics and treatment.
  • China: major contributor in both diagnostics & oncology therapeutics.
  • India: strong CAGR prospects especially in diagnostics.
  • Japan: high per capita spend and aging-driven uptake.

Europe

• Stable growth with strong universal healthcare adoption and precision medicine.
• Major markets (Germany, UK, France) contribute heavily to oncology drug and diagnostics revenues.

Rest of World

• Latin America and Middle East & Africa show rising diagnostic activities and oncology therapy access, though from smaller bases.

4. Market Growth Mix by Year (Sample Summary)

Key Observations

? North America dominates due to technology, reimbursement, and R&D infrastructure.
? Asia-Pacific is fastest growing, especially China and India, with rising disease burden fueling demand.
? Europe grows steadily, supported by public systems and precision medicine initiatives.
? Treatment market growth is larger in absolute terms versus diagnostics due to high drug costs and service complexities.
? Emerging innovation (immunotherapy, CAR-T, personalized medicine) increases treatment spend in developed markets.